Spectrum Pharmaceuticals, Inc. and FDC Ltd. announced the signing of a marketing and supply agreement under which FDC will develop and manufacture generic drug products in India, and Spectrum will pursue the regulatory approval, marketing and distribution of the approved drugs for sale in the United States. Nandan Chandavarkar, Executive Director of FDC Ltd., commented, Read more about Spectrum Pharmaceuticals And FDC Enter Into Generic Agreement[…]